Tumor-infiltrating lymphocytes (TILs) in ER+/HER2- breast cancer. Criscitiello C, Vingiani A, Maisonneuve P, Viale G, et al. Breast Cancer Res Treat 2020 Jul 3. pii: 10.1007/s10549-020-05771.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Criscitiello C, Vingiani A, Maisonneuve P, Viale G, et al. Tumor-infiltrating lymphocytes (TILs) in ER+/HER2- breast cancer. Breast Cancer Res Treat 2020 Jul 3. pii: 10.1007/s10549-020-05771.
PMID: 32621251